Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma

Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma

Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor survival rate. It is difficult to diagnose MPM at an early stage. Soluble mesothelin remains the best available biomarker for MPM, however the lack of sensitivity for early stage disease provides a motivation for...

Full description

Bibliographic Details
Main Authors: Wafaa M. Ashour, Hassan Amin, Irin M. Sabri, Aisha M. Samir, Dalia A.H. Zaki, Mona M. Fathy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-07-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Mesothelin
Osteopontin
Mesothelioma
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763812000179

Similar Items

Similar Items